Immunogenicity and Safety Study of GSK Biologicals' dTpa Vaccine, Boostrix (263855) in Pregnant Women
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Sep 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 06 Jun 2017 Planned End Date changed from 27 Dec 2017 to 20 Oct 2017.
- 06 Jun 2017 Planned primary completion date changed from 13 Oct 2017 to 21 Aug 2017.
- 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.